Skip links

Elaprase® (idursulfase)

Full Name Elaprase® (idursulfase)
Drug Elaprase
Manufacturer Takeda Pharmaceuticals U.S.A., Inc.
Route of Administration Intravenous
Site of Care Home or Healthcare Facility
Approved Indication Patients with Hunter syndrome (Mucopolysaccharidosis II, MPS II)
Disease Mucopolysaccharidosis II
Therapeutic Area Neurology, Genetics
Enrollment Form Link Enrollment Form
Phone Number 800-240-9572
Fax Number 877-220-7581
Product Website